Malfigo AT 60mg Injection
Marketer
Sunfi Pharmaceutical Private Limited
Salt Composition
Artesunate (60mg)
Overview Malfigo AT 60mg Injection
Malaria treatment with the injectable antiparasitic drug, Malfigo AT 60mg, is indicated for uncomplicated malaria cases only. This medication is administered intravenously by a qualified healthcare provider; self-injection is strictly prohibited and reserved for situations where oral medication is infeasible. Severe malaria (affecting vital organs such as the brain, lungs, or kidneys) is not treatable with this injection, nor does it offer preventative protection against malaria. Potential side effects include headache, lightheadedness, fatigue, and decreased appetite. Local reactions at the injection site, such as soreness, inflammation, or redness, may also occur. Persistent or worsening symptoms warrant immediate medical attention. Post-treatment, regular blood tests (weekly for four weeks) may be necessary to monitor parasite levels.
Primary Ingredients of Malfigo AT 60mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Malfigo AT 60mg Injection
Plasmodium infection
Major Benefits of Malfigo AT 60mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Malfigo AT 60mg Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use Malfigo AT 60mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
How Malfigo AT 60mg Injection works:
Malfigo AT 60mg Injection is an antiparasitic drug that eliminates malarial parasites by generating cytotoxic free radicals within the parasite.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Malfigo AT 60mg Injection may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Malfigo AT 60mg Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Malfigo AT 60mg Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant hazard from this medication.
DrivingUNSAFE
Administering Malfigo AT 60mg Injection might cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Malfigo AT 60mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Malfigo AT 60mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Malfigo AT 60mg Injection :
Omit a Malfigo AT 60mg Injection dose? Seek medical advice immediately.
Facts to Know About Malfigo AT 60mg Injection
| Label | Value |
|---|---|
| Chemical Type | Sesquiterpene lactones |
| Developing Habits | No. |
| Treatment Category | Antimalarial medications |
| Actions | Artemisinin-based antimalarials |
3,018 People bought this recently